NCT02523235

Brief Summary

Currently, continuous adductor canal and popliteal-sciatic nerve blocks are used commonly for lower extremity post-operative pain control, specifically for total knee arthroplasty and foot/ankle surgery, respectively. A perineural catheter used to infuse local anesthetic for postoperative analgesia may be placed at various locations along the target nerves. Investigations of single-injection peripheral nerve blocks suggest that the onset of the block might be faster with one location over the other; but, the success rates are equivalent. However, remaining unknown is whether there is an optimal location to place a perineural catheter as part of a continuous peripheral nerve block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Aug 2015

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 9, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 14, 2015

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

September 3, 2019

Completed
Last Updated

September 3, 2019

Status Verified

August 1, 2019

Enrollment Period

2.5 years

First QC Date

August 9, 2015

Results QC Date

May 30, 2019

Last Update Submit

August 29, 2019

Conditions

Keywords

moderate painsevere painsurgerypostop analgesiaTKAadductor catheterpoplital catheterfoot/ankle surgery

Outcome Measures

Primary Outcomes (1)

  • Pain (Average): Numeric Rating Scale for Pain

    Numeric Rating Scale for Pain (0-10; 0=no pain and 10=worst imaginable pain)

    Average for the day after surgery 08:00-24:00 (adductor) and the morning after surgery for 2 hours before phone call made between 10:00-noon (popliteal)

Secondary Outcomes (7)

  • Pain (Worst) :Numeric Rating Scale for Pain

    Average for the day after surgery 08:00-24:00 (adductor) and the morning after surgery for 2 hours before phone call made between 10:00-noon (popliteal)

  • Analgesic Use: IV Morphine Equivalents

    Average for Intraoperative, in the recovery room, after the recovery room until 08:00 day after surgery, and 08:00-24:00 day after surgery

  • Ambulation: Distance in Meters

    Average for morning and afternoon following surgery

  • Pain During Afternoon Physical Therapy Session

    Average during physical therapy in the afternoon following surgery

  • Number of Participants That Had Fluid Leakage Reported at Catheter Site.

    From surgery through the day after surgery

  • +2 more secondary outcomes

Study Arms (2)

proximal catheter insertion

ACTIVE COMPARATOR

Adductor canal catheters: Inserted as described by Jæger et al., 2013: "…we performed an ultrasound survey at the medial part of the thigh, halfway between the superior anterior iliac spine and the \[superior border of the\] patella. In a short axis view, we identified the femoral artery underneath the sartorius muscle, with the vein just inferior and the saphenous nerve just lateral to the artery." Popliteal catheters: Using an ultrasound, the bifurcation of the sciatic nerve will be identified in short axis and marked at a point immediately distal at which point the two main branches of the sciatic nerve are separate and a hypoechoic area can be viewed between the two. This level will be marked on the skin. The needle will be inserted to intersect the sciatic nerve 6-7 cm proximal to the mark on the skin (therefore, proximal to the sciatic bifurcation) and injection with saline used to ensure subepimyseal spread.

Drug: ropivacaine 0.2%

distal catheter insertion

EXPERIMENTAL

Adductor canal catheters: Inserted as described by Manickam et al. 2009 Popliteal catheters: Using an ultrasound, the bifurcation of the sciatic nerve will be identified in short axis and marked at a point immediately distal at which point the two main branches of the sciatic nerve are separate and a hypoechoic area can be viewed between the two. This level will be marked on the skin. The needle tip will be inserted into the hypoechoic area between the two branches of the sciatic nerve immediately distal to the sciatic nerve bifurcation between the paraneurium and epineurium (the subparaneural space/compartment). As described by Tran et al, "An adequate position was defined as the presence of circular expansion of the paraneural sheath... Once circular expansion was obtained, we injected."

Drug: ropivacaine 0.2%

Interventions

Perineural ropivacaine 0.2% at 8 mL/h (adductor) or 6 mL/h (popliteal) basal rate infusion and a 4 mL patient-controlled bolus with a 30 minute lockout

distal catheter insertionproximal catheter insertion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • undergoing surgery with an adductor canal or popliteal-sciatic perineural catheter for postoperative analgesia following primary tri-compartment knee arthroplasty or foot/ankle surgery;
  • anticipated to have at least moderate pain following surgery \[NRS\>3\]; and,
  • age 18 years or older.

You may not qualify if:

  • pregnancy (a urine pregnancy test is standard at UCSD for female patients prior to menopause who are sexually active with the opposite sex within the previous year);
  • inability to communicate with the investigators and hospital staff;
  • clinical neuropathy in the surgical extremity;
  • chronic high-dose opioid use (defined as daily use for more than 4 weeks prior to surgery of at least the equivalent of 20 mg oxycodone);
  • BMI \> 40 kg/m2;
  • allergy to study medications (lidocaine, ropivicaine);
  • known renal insufficiency; or,
  • incarceration.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University California San Diego

San Diego, California, 92103-8770, United States

Location

Related Publications (1)

  • Sztain JF, Khatibi B, Monahan AM, Said ET, Abramson WB, Gabriel RA, Finneran JJ 4th, Bellars RH, Nguyen PL, Ball ST, Gonzales FB, Ahmed SS, Donohue MC, Padwal JA, Ilfeld BM. Proximal Versus Distal Continuous Adductor Canal Blocks: Does Varying Perineural Catheter Location Influence Analgesia? A Randomized, Subject-Masked, Controlled Clinical Trial. Anesth Analg. 2018 Jul;127(1):240-246. doi: 10.1213/ANE.0000000000003422.

MeSH Terms

Conditions

Pain, PostoperativePain

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Results Point of Contact

Title
Brian Ilfeld, MD, MS
Organization
University California San Diego

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology, In Residence

Study Record Dates

First Submitted

August 9, 2015

First Posted

August 14, 2015

Study Start

August 1, 2015

Primary Completion

February 1, 2018

Study Completion

March 1, 2018

Last Updated

September 3, 2019

Results First Posted

September 3, 2019

Record last verified: 2019-08

Locations